期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

鞘内注射PI3K特异性抑制剂LY294002对小鼠骨癌痛的影响 被引量：2

Effect of Intrathecal Injection with PI3K Specific Inhibitor(LY294002) on Mice with Bone Cancer Pain
原文传递
导出
摘要 [目的]了解鞘内注射PI3K特异性抑制剂LY294002对小鼠股骨癌痛的影响。[方法]C3H/HeJ小鼠32只,随机分为对照组、假手术组、骨癌组和鞘内LY294002+骨癌组(抑制剂组),每组8只,分别于造模前和模型建立后的第8、10、12、14、17、21d测定各小鼠机械痛敏(机械缩腿阈值,mechanical withdrawal threshold,MWT)和热痛敏(热缩腿潜伏期,thermal withdrawal latency,TWL),LY294002术前鞘内注射。[结果]与术前相比较,骨癌组小鼠术后12、14、17、21dMWT明显下降(t=4.527,P=0.003;t=3.698,P=0.008;t=4.043,P=0.005;t=4.309,P=0.004),TWL明显降低(t=5.946,P=0.001;t=5.214,P=0.001;t=6.786,P=0.000;t=5.758,P=0.001);与假手术组相比较,骨癌组小鼠术后12、14、17、21dMWT明显下降(P=0.027;P=0.000;P=0.000;P=0.000),TWL明显降低(P=0.000;P=0.000;P=0.000;P=0.000)。与骨癌组相比较,抑制剂组小鼠在12、14、17、21dMWT明显升高(P=0.031;P=0.001;P=0.002;P=0.000),TWL明显延长(P=0.002;P=0.000;P=0.000;P=0.000);与术前和对照组相比较,假手术组在各时间点的MWT和TWL均无明显变化(P>0.05)。[结论]鞘内注射PI3K特异性抑制剂LY294002能明显减轻骨癌痛小鼠机械痛敏和热痛敏,提示PI3K在脊髓水平参与了骨癌痛信息传递。 [Purposel To investigate the effect of intrathecal injection PI3K specific inhibitor（LY294002） on mice with bone cancer pain. [Methods] Thirty-two C3H /HeJ mice were randomly divided into 4 groups （n=8 each）： control group, sham operation group, bone cancer group, bone cancer＋LY294002 group. The mechanical withdrawal threshold （MWT） and thermal withdrawal latency （TWL） were measured at the time of pre-operation and the 8d, 10d, 12d, 14d, 17d, 21d post operation. LY294002 was intrathecal injection before operation. [Results ] Compared with pre-operation, MWF decreased significantly in bone cancer group at the 12d, 14d, 17d, 21d post operation （t=4.527,P=0.003;t=3.698,P=0.008;t= 4.043, P =0.005 ; t =4.309, P =0.004 ） ; and TWL shortened significantly （ t =5.946, P =0.001 ; t =5.214, P = 0.001;t=-6.786,P=0.000;t=5.758,P=0.001 ）. Compared with sham group, MWT decreased significantly in the bone cancer group at the 12d, 14d, 17d, 21d post operation （P=0.027;P=0.000;P=0.000;P=0.000）, and TWL shortened significantly too （P=0.000 ; P=0.000 ; P=0.000 ; P=0.000）. Compared with bone cancer group , MWT increased significantly in bone cancer＋ LY294002 group at the 12d,14d,17d,21d post oper- ation （P=0.031 ; P=0.001 ; P=0.002 ; P=0.000）, and TWL prolonged significantly at the 12d, 14d, 17d,21 d after operation （P=0.002 ;P=0.000;P=0.000 ;P=0.000）. Compared with pre-operation and control group, MWT, TWL in each point of time ＇after operation in sham operation group did not change significantly（P〉 0.05）. [Conclusion ] Intrathecal injection with PI3K specific inhibitor （LY294002 can obviously relieve heat hyperalgesia in mice with bone cancer pain. It suggests that PI3K may play an important role in the nociceptive transmission on the spinal level.
作者 龚琴 区锦燕 廖荣宗 罗富荣 邹功胜 胡兴国 曾因明
机构地区 广东省佛山市中医院 徐州医学院江苏省麻醉医学研究所
出处 《肿瘤学杂志》 CAS 2010年第1期46-49,共4页 Journal of Chinese Oncology
基金 广东省卫生厅基金资助课题(A2008680)
关键词 骨癌痛 脊髓 LY294002 小鼠 bone cancer pain spinal cord LY294002 mice
分类号 R73-36 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositide 3-kinases: implications for development,homeostasis, and cancer[J]. Annu Rev Cell Dev Biol, 2001, 17: 615-675.
  • 2Sun R, Yan J, Willis WD. Activation of protein kinase B/ Akt in the periphery contributes to pain behavior induced by capsaicin in rats[J]. Neuroseienee, 2007, 144(1):286- 294.
  • 3Pezet S, Marchand F, D'Mello R, et al. Phosphatidylinositol 3-kinase is a key mediator of central sensitization in painful inflammatory conditions [J]. J Neurosci, 2008, 28 (16):4261-4270.
  • 4Schwei MJ, Honore P, Rogers SD, et al. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain [J]. J Neurosci, 1999, 19(24): 10886-10897.
  • 5Chaplan SR, Bach FW, Pogrel JW, et al. Quantitative assessment of tactile allodynia in the rat paw [J]. J Neurosci Methods, 1994, 53(1): 55-63.
  • 6Hargreaves K, Dubner R, Brown F, et al. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia[J]. Pain, 1988, 32(1): 77-88.
  • 7Ward SG, Finan P. Isoform-specific phosphoinositide 3-kinase inhibitors as therapeutic agents[J]. Curropin Pharmacol, 2003,3(4): 426-434.
  • 8Xu JT, Tu HY, Xin WJ, et al. Activation of phosphatidylinositol 3-kinase and protein kinase B/Akt in dorsal root ganglia and spinal cord contributes to the neuropathic pain induced by spinal nerve ligation in rats[J]. Exp Neurol, 2007, 206(2):269-279.
  • 9Zhu W, Oxford GS. Phosphoinositide-3-kinase and mitogen activated protein kinase signaling pathways mediate acute NGF sensitization of TRPV1 [J]. Mol Cell Neurosci, 2007, 34(4):689-700.
  • 10Ma W, Chabot JG, Quirion R. A role for adrenomedullin as a pain-related peptide in the rat[C]. Proc Natl Acad Sci USA, 2006, 103(43):16027-16032.

同被引文献44

  • 1马正良,夏小萍,朱巍,业光衡,韩鹂,费强.小鼠骨癌痛模型的建立及痛行为学和骨损害的观察[J].中国疼痛医学杂志,2007,13(5):288-292. 被引量：18
  • 2Katso R, Okkenhaug K, Ahmadi K, et al. Cellular function of phosphoinositeds 3-kinases: implications for develop- ment,homeostasis,and cancer[J]. Annu Rev Cell Dev Biol, 2001,17(1): 615-675.
  • 3Song G, Ouyang G, Bao S. The activation of Akt/PKB sig- naling pathway and cell survival[J]. J Cell Mol Med, 2005, 9(1): 59-71.
  • 4Sharrard RM, Maitland NJ. Regulation of protein kinase B activity by PTEN and SHIP2 in human prostate-derived cell lines[J]. Cell Signal,2007,19(1): 129-138.
  • 5Akca H, Demiray A,Tokgun O, et al. Invasiveness and an- chorage independent growth ability augmented by PTEN inactivation through the PI3K/AKT/NFkB pathway in lung cancer cells[J]. Lung Cancer,2011,73(3): 302-339.
  • 6Presneau N, Shalaby A, Idowu B, et al. Potential therapeu- tic targets for chordoma: P13K/AKT/TSC1/TSC2/mTOR pathway[J]. Br J Cancer,2009,100(9): 1406-1414.
  • 7Wang L,Cao XX,Chen Q,et al. DIXDC1 targets p21 and cyclin D1 via PI3K pathway activation to promote colon cancer cell proliferation[J]. Cancer Sei,2009,100(10): 1801 - 1808.
  • 8Liu H,Xu J,Zhou L,et al. Hepatitis B virus large surface antigen promotes liver carcinogenesis by activating the Src/PI3K/Akt pathway[J]. Cancer Res,2011,71 (24) :7547- 7557.
  • 9Campbell RA,Bhat-Nakshatei P,Patel NM,et al. Phos- phatidylinositol 3-kinase/AKT-mediated activation of es- trogen receptor alpha: a new model for anti-estrogen resis- tance[J]. J Biol Chem,2001,276(13): 9817-9824.
  • 10Shultz JC,Goehe RW,Wijesinghe DS,et al. Alternative splicing of caspase 9 is modulated by the phosphoinosi- tide 3-kinase/Akt pathway via phosphorylation of SRp30a [J]. Cancer Res,2010,70(22): 9185-9196.

引证文献2

二级引证文献35

肿瘤学杂志
2010年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部